ArticleBMJ open2021

Reporting of adverse events, conflict of interest and funding in randomised controlled trials of antibiotics: a secondary analysis.

Mina Bakhit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.